CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bayer Healthcare LLC v. Apotex Inc.

1:16-cv-01221

Overview

Case Number 1:16-cv-01221
Filing Date 2016-12-16
Status Terminated
Termination Date 2020-08-17
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Apotex Corp. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Apotex Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Teva Pharmaceutical Industries, Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Bayer HealthCare Pharmaceuticals Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Bayer Healthcare LLC Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 1 proceeding
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2016-07-25
IPR2016-01490

Fustibal LLC v. Bayer HealthCare LLC

U.S. Continuation Sibling (8637553)
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7351834
Ο‰-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
Filed: 2000-01-12
Issued: 2008-04-01
Expired (Term Ended) +898d PTA
Expires: 2022-06-28
US8637553
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
Filed: 2004-07-22
Issued: 2014-01-28
Active (4.2 yrs remaining) +2400d PTA
Expires: 2031-02-16
US8680124
Treatment of cancers with acquired resistance to kit inhibitors
Filed: 2008-01-18
Issued: 2014-03-25
Active (3.5 yrs remaining) +866d PTA
Expires: 2030-06-02
US9458107
Process for the preparation of 4-{4-[({[4 chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorphenoxy-N-ethylpyridie-carboxamide, its salts and monohydrate
Filed: 2014-04-15
Issued: 2016-10-04
Active (7.4 yrs remaining)
Expires: 2034-04-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+898 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

4

Motions by Category

Procedural / Extension Motion 3 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 9/4/2018. Status Report due by 6/8/2018. Claim Constr...
Entry #20 • 2017-11-13 Document →
Procedural / Extension Motion Pending / Under Review
Joint PROPOSED ORDER - Scheduling Order re (15 in 1:16-cv-01221-LPS, 13 in 1:17-cv-00334-LPS, 13 in 1:16-cv-01222-LPS) STIPULATION TO EXTEND TIME to meet and co...
Entry #16 • 2017-07-12 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to meet and confer to arrive at a proposed scheduling order to July 12, 2017 - filed by Bayer HealthCare Pharmaceuticals Inc., Bayer ...
Entry #15 • 2017-07-07 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Respond to the Complaint to February 21, 2017 - filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc.. (Ke...
Entry #8 • 2017-01-09 Document →

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2048907.) - filed by Bayer Healthcare LLC, Bayer HealthCare Pharmaceuticals Inc. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(cna) (Entered: 12/19/2016)

Entry #1 • 2016-12-16
1
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2048907.) - filed by Bayer Healthcare LLC, Bayer HealthCare Pharmaceuticals Inc. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(cna) (Entered: 12/19/2016)

Entry #1 • 2016-12-16
2
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2048907.) - filed by Bayer Healthcare LLC, Bayer HealthCare Pharmaceuticals Inc. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(cna) (Entered: 12/19/2016)

Entry #1 • 2016-12-16
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cna) (Entered: 12/19/2016)

Entry #2 • 2016-12-16
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,351,834 B1; 8,637,553 B2; 8,680,124 B2; 9,458,107 B2. (cna) (Entered: 12/19/2016)

Entry #3 • 2016-12-16
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc